In the 1980s, the Slavic researchers whom we have to thank for the bulk of our knowledge about short peptides were focused on the possibilities of a thymic peptide bioregulator called thymalin which they found could spur the thymus to re-grow, thus enhancing immune function
Additionally, Dihexas small molecular weight of 750 Da allows blood-brain barrier penetration approximately 1000-fold more efficient than BDNF, which is too large to cross the BBB effectively when administered peripherally
The results are not directly comparable because the peptides are not equivalent products
Furthering the scope of BPC-157s potential benefits in ED treatment, it is ripe for synergistic combination with other traditional and emerging treatments
BPC-157 is not approved for human use and is strictly intended for laboratory research only (RUO)
These products are not medicines, drugs, or dietary supplements and have not been approved by the U.S